|
⚲
|
| Keyboard |
| OrbiMed Israel GP II LP | |
|---|---|
| Firm | OrbiMed Advisors LLC |
| Address | c/o OrbiMed Advisors LLC 601 Lexington Avenue, 54th Floor New York, NY 10022 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | |||||
| OrbiMed Israel Partners II LP | 021-253036 | Executive Officer | of 300.0 M |
298.5 M | |
| Related People Network |
|---|
| Network #144 at OrbiMed Advisors LLC — files alongside 6 co-filers |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Adicet Bio Inc ACET
Common Stock
|
2025-10-08 | Buy | 3,500,000 | $1.00 | 3,500,000 |
|
Adicet Bio Inc ACET
Common Stock
|
2025-10-08 | Buy | 1,500,000 | $1.00 | 1,500,000 |
|
Upstream Bio Inc UPB
Common Stock
|
2024-10-15 | Buy | 165,000 | $17.00 | 2,805,000 |
|
Upstream Bio Inc UPB
Common Stock
|
2024-10-15 | Buy | 660,000 | $17.00 | 11,220,000 |
|
Upstream Bio Inc UPB
Common Stock
|
2024-10-15 | Conversion | 721,956 | ||
|
Upstream Bio Inc UPB
Common Stock
|
2024-10-15 | Conversion | 2,887,833 | ||
|
Upstream Bio Inc UPB
Series A redeemable convertible preferred stock · derivative
|
2024-10-15 | Conversion | 524,500 | ||
|
Upstream Bio Inc UPB
Series A redeemable convertible preferred stock · derivative
|
2024-10-15 | Conversion | 2,098,000 | ||
|
Upstream Bio Inc UPB
Series B redeemable convertible preferred stock · derivative
|
2024-10-15 | Conversion | 197,456 | ||
|
Upstream Bio Inc UPB
Series B redeemable convertible preferred stock · derivative
|
2024-10-15 | Conversion | 789,833 | ||
|
Adicet Bio Inc ACET
Common Stock
|
2024-01-25 | Buy | 242,200 | $2.40 | 581,280 |
|
Adicet Bio Inc ACET
Common Stock
|
2024-01-25 | Buy | 1,041,700 | $2.40 | 2,500,080 |
|
Adicet Bio Inc ACET
Common Stock
|
2024-01-25 | Buy | 1,841,100 | $2.40 | 4,418,640 |
|
Damora Therapeutics Inc GLTO
Common Stock
|
2023-08-15 | Sell | 38,327 | $0.75 | 28,745 |
|
Damora Therapeutics Inc GLTO
Common Stock
|
2023-08-15 | Sell | 248,819 | $0.75 | 186,614 |
|
Damora Therapeutics Inc GLTO
Common Stock
|
2023-08-15 | Sell | 535,534 | $0.75 | 401,650 |
|
Damora Therapeutics Inc GLTO
Common Stock
|
2023-07-31 | Sell | 29,700 | $3.00 | 89,100 |
|
Damora Therapeutics Inc GLTO
Common Stock
|
2023-07-31 | Sell | 153,078 | $3.00 | 459,234 |
|
Damora Therapeutics Inc GLTO
Common Stock
|
2023-07-31 | Sell | 26,622 | $3.00 | 79,866 |
|
Damora Therapeutics Inc GLTO
Common Stock
|
2023-07-25 | Sell | 7,800 | $2.92 | 22,776 |
| showing 20 of 112 most recent transactions | |||||